Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma|Breast Ductal Carcinoma In Situ|Breast Lobular Carcinoma In Situ|Estrogen Receptor-Positive Breast Carcinoma
Interventions: PROCEDURE: Biopsy|PROCEDURE: Biospecimen Collection|PROCEDURE: Mammography|OTHER: Questionnaire Administration|DRUG: Tamoxifen
Sponsor: National Cancer Institute (NCI)